We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R

News   Nov 04, 2013

 
Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R
 
 
 

RELATED ARTICLES

HPV-Positive Throat Cancer Patients Should Keep Taking Chemotherapy

News

Patients with human papillomavirus (HPV)-positive throat cancer should carry on receiving chemotherapy rather than switching to a targeted cancer drug during curative radiotherapy, new clinical trial results have shown.

READ MORE

Peanut Allergy Treatment Ready for FDA Review

News

Study shows it is possible for some people with peanut allergy to protect themselves from accidental ingestion by building up their tolerance to peanut over time.

READ MORE

Scorpion Venom Can Shuttle Drugs into the Brain

News

Researchers at IRB Barcelona modify chlorotoxin—a small protein present in scorpion venom with blood-brain barrier permeability—to transport drugs into the brain.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE